PD-L1

ATL
Xinxin Zhu, Ling Zhao, Jinghe Lang

International Journal of Gynecologic Cancer Oct 2018, 28 (8) 1514-1519; DOI: 10.1097/IGC.0000000000001334
Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data
Marlene Kranawetter, Sebastian Röhrich, Leonhard Müllauer, Helena Obermair, Alexander Reinthaller, Christoph Grimm, Alina Sturdza, Wolfgang J. Köstler, Stephan Polterauer

International Journal of Gynecologic Cancer Jun 2018, 28 (6) 1196-1202; DOI: 10.1097/IGC.0000000000001291
Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency
Zaibo Li, Amy S. Joehlin-Price, Jennifer Rhoades, Martins Ayoola-Adeola, Karin Miller, Anil V. Parwani, Floor J. Backes, Ashley S. Felix, Adrian A. Suarez

International Journal of Gynecologic Cancer Jan 2018, 28 (1) 59-68; DOI: 10.1097/IGC.0000000000001120
PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes
Pierre-Adrien Bolze, Sophie Patrier, Jérôme Massardier, Touria Hajri, Fatima Abbas, Anne Marie Schott, Fabienne Allias, Mojgan Devouassoux-Shisheboran, Gilles Freyer, François Golfier, Benoît You

International Journal of Gynecologic Cancer Mar 2017, 27 (3) 554-561; DOI: 10.1097/IGC.0000000000000892

Main menu